Meridian Clinical Research is categorized under Commercial Medical Research in Omaha, NE and active since 2000.
Meridian Clinical Research was established in 2000, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Lori Brown, Owner at the company’s single location by writing to 3319 North 107th St, Omaha, Nebraska NE 68134 or by phoning (402) 933-6500. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Meridian Clinical Research |
| Contact Person: | Lori Brown, Owner |
| Address: | 3319 North 107th St, Omaha, Nebraska 68134 |
| Phone Number: | (402) 933-6500 |
| Website Address: | mcrmed.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417115 |
| Share This Business: |
Meridian Clinical Research was started in 2000 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Lori Brown, Owner for inquiries that concern Meridian Clinical Research by calling the company number (402) 933-6500, as your correspondence is most welcome. Additionally, the physical location of the single location of Meridian Clinical Research can be found at the coordinates 41.28889,-96.08024 as well as the street address 3319 North 107th St in Omaha, Nebraska 68134.
For its online presence, you may visit Meridian Clinical Research’s website at mcrmed.com and engage with its social media outlets through on Twitter and on Facebook.